Mesenteric venous thrombosis associated with estrogen therapy for treatment of prostatic carcinoma.
We report 2 cases of mesenteric venous thrombosis in men taking estrogen for carcinoma of the prostate. The possible relationship between the estrogen therapy and mesenteric venous thromboses is stressed, as well as the potential danger of resumption of estrogen therapy without anticoagulation postoperatively.
D000368:Aged; D002741:Chlorotrianisene / Q000009:adverse effects* / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008641:Mesenteric Vascular Occlusion / Q000139:chemically induced*; D008642:Mesenteric Veins; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced*
D002741:Chlorotrianisene; D004054:Diethylstilbestrol